Effects of different mycotoxins on humans, cell genome and their involvement in cancer (Review)

被引:79
作者
Adam, Mowaffaq Adam Ahmed [1 ]
Tabana, Yasser M. [1 ]
Musa, Khirun Binti [1 ]
Sandai, Doblin Anak [1 ]
机构
[1] Univ Sains Malaysia, Adv Med & Dent Inst, Infect Cluster, Kepala Batas 13200, Penang, Malaysia
关键词
mycotoxins; cancer; aflatoxins; THIN-LAYER-CHROMATOGRAPHY; GLUTATHIONE-S-TRANSFERASE; NEURAL-TUBE DEFECTS; WORLD-WAR-II; OCHRATOXIN-A; FUMONISIN B-1; AFLATOXIN B-1; T-2; TOXIN; ASPERGILLUS-PARASITICUS; LIVER-CANCER;
D O I
10.3892/or.2017.5424
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The chemical nature of most of the mycotoxins makes them highly liposoluble compounds that can be absorbed from the site of exposure such as from the gastrointestinal and respiratory tract to the blood stream where it can be dissimilated throughout the body and reach different organs such as the liver and kidneys. Mycotoxins have a strong tendency and ability to penetrate the human and animal cells and reach the cellular genome where it causes a major mutagenic change in the nucleotide sequence which leads to strong and permanent defects in the genome. This defect will eventually be transcribed, translated and lead to the development of cancer. In this review, the chemical and physical nature of mycotoxins, the action of mycotoxins on the cellular genome and its effect on humans, mycotoxins and their carcinogenicity and mycotoxins research gaps are discussed, and new research areas are suggested. The research review posed various questions. What are the different mycotoxins that can cause cancer, what is the role of mycotoxins in causing cancer and what types of cancers can be caused by mycotoxins? These questions have been selected due to the significant increase in the mycotoxin contamination and the cancer incidence rate in the contemporary world. By revealing and understanding the role of mycotoxins in developing cancer, measures to reduce the risks and incidents of cancer could be taken.
引用
收藏
页码:1321 / 1336
页数:16
相关论文
共 239 条
[21]   MURINE LYMPHOCYTE-PROLIFERATION IMPAIRED BY SUBSTITUTED NEOSOLANIOLS AND CALONECTRINS - FUSARIUM METABOLITES ASSOCIATED WITH TRICHOTHECENE BIOSYNTHESIS [J].
BONDY, GS ;
MCCORMICK, SP ;
BEREMAND, MN ;
PESTKA, JJ .
TOXICON, 1991, 29 (09) :1107-1113
[22]   Genotoxic potential associated with low levels of the Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal cell line [J].
Bony, S. ;
Olivier-Loiseau, L. ;
Carcelen, M. ;
Devaux, A. .
TOXICOLOGY IN VITRO, 2007, 21 (03) :457-465
[23]   RENAL LESIONS INDUCED BY OCHRATOXIN-A EXPOSURE IN THE F344 RAT [J].
BOORMAN, GA ;
MCDONALD, MR ;
IMOTO, S ;
PERSING, R .
TOXICOLOGIC PATHOLOGY, 1992, 20 (02) :236-245
[24]   Individual and combined effects of ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and on chromosome aberrations in mice bone marrow cells [J].
Bouslimi, Amel ;
Bouaziz, Chayma ;
Ayed-Boussema, Imen ;
Hassen, Wafa ;
Bacha, Hassen .
TOXICOLOGY, 2008, 251 (1-3) :1-7
[25]   Interpreting the international trends in testicular seminoma and nonseminoma incidence [J].
Bray, Freddie ;
Ferlay, Jacques ;
Devesa, Susan S. ;
McGlynn, Katherine A. ;
Moller, Henrik .
NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (10) :532-543
[26]   Stability of mycotoxins during food processing [J].
Bullerman, Lloyd B. ;
Bianchini, Andreia .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2007, 119 (1-2) :140-146
[27]   ISOLATION AND PURIFICATION OF OCHRATOXIN-A [J].
BUNGE, I ;
HELLER, K ;
ROSCHENTHALER, R .
ZEITSCHRIFT FUR LEBENSMITTEL-UNTERSUCHUNG UND-FORSCHUNG, 1979, 168 (06) :457-458
[28]   ALTERATION OF MULTIPLE CELL-MEMBRANE FUNCTIONS IN L-6 MYOBLASTS BY T-2 TOXIN - AN IMPORTANT MECHANISM OF ACTION [J].
BUNNER, DL ;
MORRIS, ER .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 92 (01) :113-121
[29]  
BUTLER WH, 1969, CANCER RES, V29, P2206
[30]   Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient [J].
CaballeroGranado, FJ ;
Viciana, P ;
Cordero, E ;
GomezVera, MJ ;
delNozal, M ;
LopezCortes, LF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1207-1207